학술논문
A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector
Document Type
Abstract
Author
Source
In Journal of Molecular and Cellular Cardiology 31 December 2022 173 Supplement:113-113
Subject
Language
ISSN
0022-2828